article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

Christopher Riley is a forward-thinking, financially astute finance and operation’s executive with talent for re-engineering, building, and profitably growing businesses to achieve significant shareholder value in medical technology and consumer product markets for multinational & entrepreneurial organizations.

article thumbnail

The Venture Valkyrie’s Next AdVenture

Health Populi

While she’s best-known for being a very visible woman in health-technology investing and building venture funds, Lisa is social media savvy well beyond the profiles of those in her tech-investing peer group. Lisa started the Venture Valkyrie blog in 2010. So the apple didn’t fall too far from the paternal tree.